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Abstract 
 
POULIOT, KATHERINE Evaluating the effectiveness of Care Choices, 
 a home-based palliative care program. 
Departments of Biological Sceinces and Psychology, June 2016. 
 
ADVISOR: Carol Weisse PhD 
   
Background:  There is a growing need for home-based palliative care services, 
especially for seriously ill individuals who want to avoid unnecessary hospitalizations 
and remain with their regular outside care providers.   
Objective: To evaluate the effectiveness of Care Choices, a new in-home palliative care 
program provided by the Visiting Nurse Services of Northeastern New York and Ellis 
Medicine, a community healthcare system serving New York’s Capital District.  
Design: A prospective cohort study tracking patient outcomes over the course of one 
year. 
Subjects and setting:  One hundred twenty-three patients (49 men, 74 women) with 
serious illnesses who were new enrollees in Care Choices  
Measurements:  Patient satisfaction, symptom management, and hospital utilization 
were used to measure effectiveness. Phone interviews were conducted assessing 
satisfaction after one month of care and again around three months later.  Quality of life 
was assessed at baseline and after 1 month on service.  The number of emergency room 
visits and in-patient hospitalizations was recorded pre- and post-enrollment.   
Results:  Patients were highly satisfied with their initial care and reported greater 
satisfaction and stable symptom management over time.  Fewer emergency room and 
inpatient hospital admissions occurred while enrolled in the program. 
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Conclusion: An in-home palliative care program offered jointly through a visiting 
nurse service and community hospital may be a successful model for providing quality 
care that satisfies chronically ill patients’ desire to remain at home, avoid hospital 
admissions, and retain the option of outside care while on the program.
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Introduction	  	  
 Currently, the United States is experiencing a healthcare crisis as medical 
interventions prolong life, life expectancy increases, and costs grow relentlessly.1 People 
are living longer but also experiencing chronic illnesses associated with aging that require 
specialized care that many acute care hospitals are ill-prepared to manage.  It has been 
predicted that over 81 million Americans will suffer from multiple chronic illnesses by 
2020. 2,3 This rapidly changing illness landscape along with changes driven by the 
Affordable Care Act has resulted in significant efforts to restructure the delivery of health 
care.  This is especially true for elderly members of the community whose declining 
health prompts increased demand on resources for conditions that have no cure.	  
The Institute for Healthcare Improvement (IHI) has proposed a framework for 
maximizing a health care system’s effectiveness that includes three key components: 
improving quality of care and patient satisfaction, improving health outcomes, and 
reducing costs. 4 One key way of achieving this “triple aim” is to introduce palliative care 
early in the evolution of chronic illness.  Palliative care is increasingly recognized as a 
vital component of care for seriously ill patients and their families.  Several studies have 
shown that early in-home palliative care services can improve a number of patient 
outcomes including increasing satisfaction and quality of life, 5, 6 improving survival7, 
and reducing the use of hospitalization services and healthcare costs. 8, 9  
It has been persuasively argued that palliative care needs to be introduced earlier 
on and not be solely administered in hospital settings. 7 Patients treated in a home setting 
have been shown to have better physical and psychological health and better quality of 
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life compared to those treated in a hospital.10 By delivering palliative care in the home, it 
is possible to improve quality of life earlier on and likely circumvent the need for 
unnecessary hospitalizations.  Additionally, in-home palliative care initiatives have been 
taking form due to patient preference, convenience, and increasing need of care for 
chronically ill populations who cannot go to a healthcare facility. Commonly patients 
suffering with chronic illness have decreased mobility due to symptoms leading to 
difficulties in transport.11 Using in-home care alleviates the physical, financial and 
emotional burden associated with transportation. Patient’s comfort and independence are 
also better respected in the care of their own home, leading to a higher satisfaction of 
care.8, 11 To keep patients in this setting, it is important that complex symptoms that can 
lead to hospitalization are managed. Symptoms such as dyspnea, pain, nausea and anxiety 
have been shown to prompt hospitalizations and disrupt the preferred care setting.12 
 Dyspnea, the feeling of uncomfortable awareness of breathing, 13 is a prevalent 
symptom in seriously, chronically ill patients suffering from diagnoses like cancer, 
cardiovascular disease, and secondary conditions such as chronic obstructive pulmonary 
disease and asthma.13-15 There are several options available for alleviating dyspnea that 
can be offered to patients in the home. In many cases, the most effective way of treating 
dyspnea is by treating the underlying problem. For example, hypoxemia, a contributing 
factor in most cases of dyspnea can be treated using oxygen therapy.13 When dyspnea is 
the result of inflammation, corticosteroids can be prescribed to reduce swelling in 
patient’s airways.14 Opioids are an additional drug intervention for treating dyspnea.13, 16 
There are also nonpharmacologic approaches to treating dyspnea in the home. For 
example, patients can be encouraged to try activity pacing to reduce symptoms 
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throughout the day and to try relaxation techniques to lessen the pace of breathing. If 
breathlessness can be improved at home, this can keep patients out of the hospital and in 
their most comfortable setting.  
 Some treatments of dyspnea can be used to treat other symptoms common in 
seriously ill populations. For example, opioids can be used to treat pain – the top 
symptom reported in hospital and outpatient palliative care programs. Pain can take a 
variety of forms: pain that is episodic, where pain can occasionally breakthrough opioid 
use, pain that responds poorly to opioid use, or pain that is caused by non-physical 
factors, such as psychosocial stress.17 These characterizations and causes makes pain a 
difficult symptom to control in the home.18Pain, like dyspnea, can be managed with both 
pharmacologic and nonpharmacologic treatments.18-20  
 Nonpharmacologic approaches toward treatment focus on manipulating 
psychosocial factors that can contribute to pain.20 Cognitive control techniques, in which 
patients regulate psychological aspects of their symptoms, work by emphasizing deep 
breathing exercises and making positive statements. Distraction techniques, where 
patients direct their attention away from painful stimuli, can also be used. Both cognitive 
control and distraction techniques have been shown to be effective in pain management.20 
After treatment options like these are taught, patients can use them in their homes or at 
anytime they are experiencing pain. 
 Pharmacologic treatments for pain are used depending on the characterization of 
the pain; some approaches treat the symptom while others treat the underlying cause. 
Patients that have pain resulting from nerve damage typically are prescribed gabapentin.18 
Gabapentin reduces the release of the neurotransmitter glutamate, which is involved in 
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the excitement of nerves. Corticosteroids, such as dexamethasone, can be used to reduce 
inflammatory responses and the pain associated with the response. Most frequently, 
patients are prescribed opioids such as morphine, the recommended opioid to control 
pain, but other opioids like fentanyl dermal patches, methadone and oxycodone are 
sometimes also used.18, 19 Though opioids can be beneficial for in-home treatment of 
pain, side effects such as nausea and vomiting also need to be managed. It has been 
shown that about 40% of patients using opioid treatments experience opioid-induced 
nausea and vomiting.21 In addition, patients who are opioid users have a tendency to have 
gastroesophageal reflux disease and other gastrointestinal issues.22 Nausea is a common 
problem affecting all chronically ill populations, whether it is the result of primary 
disease diagnosis, side effects of therapies and medications, or unrelated comorbidities.23, 
21 To treat all varieties of nausea there are a vast array of options ranging from 
pharmacologic to alternative medicine treatments.  
 The most frequently prescribed pharmaceutical for acid reflux disease, a main 
cause of nausea, is prokenitics.21 Prokinetics reduce nausea by strengthening the lower 
esophageal sphincter so that stomach acid cannot climb up the esophagus. When 
seriously ill patients develop intractable vomiting and nausea, commonly caused by 
chemotherapy, dopamine receptor antagonists, antihistaminic agents and selective 5HT 
receptor antagonists can be used.21 Nonpharmacologic approaches can be combined with 
medications and are encouraged for all patients who suffer from nausea and vomiting. 
Patients can be encouraged to stay away from stimuli that cause their nausea and to try 
herbal remedies such as ginger or pepermint.21 Recent studies also suggest that 
alternative medicine approaches such as acupuncture and massage therapy could be 
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helpful in alleviating nausea in a palliative setting.21 These treatments are all suitable for 
in-home care, and therefore offer hope that symptoms associated with serious illness can 
be managed at home by an in-home care support program. 
 When suffering with symptoms like nausea, seriously ill patients also have a 
higher likelihood of experiencing anxiety.24 Nausea and anxiety are so interconnected 
that, in order to treat certain cases of nausea, benzodiazepines, such as lorazepam, are 
often prescribed.21 Anxiety is unique in that its treatment can include the use of social 
workers in addition to traditional antianxiety medications. Social workers have been 
shown to significantly reduce patient anxiety by helping patients solve problems 
associated with serious illness, and by helping them to find financial resources.25 Using 
in-home social work has been shown to increase rates of remission and lower severity of 
anxiety.25 If improvement of anxiety can be achieved in the home, patients should 
experience a higher rate of satisfaction and an increase in wellbeing, factors that may also 
keep patients out of the hospital.26 
Palliative care programs are on the rise and if symptoms like dyspnea, pain, 
nausea and anxiety can be well controlled in the home, this can improve patient’s quality 
of life while reducing resource use8. According to the Center to Advance Palliative Care, 
as of 2010 66%, of U.S. hospitals with more than 50 beds had a palliative care team and 
88% of hospitals with more than 300 beds provide palliative care teams.10 This growing 
capacity is a sign of positive change. In order to expand palliative care to the home, 
hospitals could partner with visiting nurse services to keep patients where they desire to 
be-in the home. 
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 Visiting Nurse Associations of America (VNAA) are evolving to expand their 
services to include palliative and end of life care to allow the visiting nurses to respond to 
healthcare needs across the full continuum of care and to control symptoms like dyspnea, 
pain, nausea and anxiety.27 Visiting nurse organizations are well-positioned to meet the 
growing needs for home-based care for chronic disease management and palliative care 
in seriously ill members of the community who may be ineligible for, or unwilling to 
consider, hospice services.  In New York’s Capital District, the Visiting Nurse Services 
of Northeastern New York partnered with Ellis Medicine, a community health system, to 
launch a new in-home palliative care program called Care Choices. The program offers 
interdisciplinary in-home care by a team (medical director, nurse, social worker, 
chaplain, and home health aides) exclusively dedicated to palliative home care to meet 
the patient’s physical, emotional and spiritual needs.   
 Care Choices was initiated through the use of reserve funds of the Visiting Nurse 
Service of Northeastern New York, an affiliate of Ellis Medicine.  Currently, Care 
Choices operations are paid for by existing reimbursement mechanisms for Certified 
Home Health Agency (CHHA) home health care service, supplemented by grants and 
fund-raising.  Approximately 75% of the total expense budget is covered by CHHA 
reimbursement with the remaining being covered by grants and private fundraisers.  
Approximately 50% of Care Choices patients are covered by commercial insurance 
companies, including Medicare and Medicaid managed care products.  These companies 
are developing contracts with Care Choices to establish a palliative home care per diem 
reimbursement that supplements the CHHA rates in recognition of the additive services 
that the Care Choices program provides.  
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 In addition to skilled nursing, home visits offer education about pain and 
symptom management, psychosocial and spiritual support, anticipatory guidance for 
problem solving at home to avoid unnecessary hospitalizations, management of 
medications, communication among caregivers and providers, and facilitation of 
conversations related to serious illness, goals of care, and advance directive planning. 
Enrollees are not required to give up their outside care providers and remain under the 
care of their primary care physicians.  For patients who become medically appropriate for 
hospice, they are counseled regarding transfer to a certified Hospice program.  This 
report presents an assessment of the Care Choices program in meeting its intended goals 
of symptom management, quality of life, satisfaction with care, and a proxy for cost 
savings. 
Methods 
Participants 	  
 A review of patient records was completed on all patients in the Care Choices 
palliative care program who were first time enrollees between March 1st 2014, and March 
7th 2015.  All patients were referred internally from the existing Certified Home Health 
Agency (CHHA) caseload, from the Ellis Medicine health system, or from physicians in 
private practice. The admission criteria were serious illness diagnosis (any disease, any 
age), evidence of symptomology (recent ER visit or hospitalization), desire to stay at 
home, and eligibility for CHHA admission. The patient’s attending physician and the 
Care Choices admission nurse verified patient appropriateness. The sample included 123 
(49 men; 74 women) patients of the 235 original enrollees.  All patient were from New 
York’s Capital district with the majority (N= 109) from Schenectady County and the rest 
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from Saratoga County (N=11) and Albany County (N= 3). The average age of the 
participants was 79.37 (range 48 to 102).  
Measures 
 Patient demographic and admission data including patient’s identification code, 
date of birth, sex, zip code, admission date, discharge date, and reason for discharge were 
obtained via Allscripts (Chicago, IL), the electronic medical record used by the visiting 
nurse service.   Quality of life was measured using a modified Edmonton Symptom 
Assessment Survey ESAS. 28, 29 The survey included questions that asked patients to rate 
their symptoms on a scale from 0 to 10, with 0 representing the best and 10 representing 
the worst possible.  Symptoms included in the survey included pain, nausea, fatigue, 
depression, anxiety, appetite, dyspnea and overall well-being.  Satisfaction with Care 
Choices was measured using a modified Reid Gundlach 10-question satisfaction survey.30  
Sample items included “Overall I think the services provided by the Care Choices 
program are…” and “the staff treats me like I am an individual with unique needs and 
concerns” and “The information I have received in the program has generally been…”  
Possible responses ranged from “poor” to “excellent” or from “easy to understand” to 
“difficult to understand.”  Hospitalization data was obtained through Ellis Medicine using 
patient identification codes to determine the number of admissions to the emergency 
room pre-and post-enrollment in Care Choices and number of inpatient admissions pre- 
and post-enrollment in Care Choices.  The window of time for patient hospitalizations 
was based on each enrollee’s time on the Care Choices program. For example, if a 
patient had been enrolled in the program for 2 months, then hospitalization records over a 
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two-month time period prior to enrollment was used for comparison.  All data was 
analyzed using the IBM Statistics Package of the Social Sciences (SPSS) version 19. 	  
Procedure 
 In order assess to quality of life the ESAS was administered telephonically at two 
different time points, baseline (ESAST1) and approximately one month later (ESAST2).8  
Callers determined whether they could interview patients directly or whether a another 
person (i.e. caregiver) would be providing information on the patient’s behalf.  Questions 
were presented in a consistent, neutral tone to minimize bias. 	  
 Reid-­‐Gundlach	  Satisfaction	  surveys	  were	  conducted	  telephonically	  approximately	  1	  month	  after	  enrollment	  (RGT1)	  and	  again	  three	  months	  later	  (RGT2).	  8	  	  	  	  Surveys	  were	  introduced	  in	  the	  same	  manner	  as	  the	  ESAS	  including	  whether	  the	  patient	  or	  caregiver	  would	  be	  completing	  the	  survey.	  	  	  
Results	  
 Initial analyses were aimed at identifying the demographics of Care Choices 
enrollees from 3/1/2014 through 3/7/2015.  During this time period, 235 were enrolled, of 
which123 responded to calls yielding a 52% response rate.  The primary diagnoses of 
these respondents were: circulatory system (27.6%, N=34), cancer and neoplasms 
(23.6%, N=29), respiratory system (17.1%, N=21), nervous system and sense organs 
(6.5%, N=8), endocrine nutritional metabolic and blood forming organs (5.7%, N=7), 
surgical (4.9%, N=6), skin subcutaneous, musculoskeletal system and connective tissues 
(4.1%, N=5), genitourinary system (3.3%, N=4), digestive system (2.4%, N=3), other ill-
defined conditions (2.4%, N=3), injuries and poisonings (0.8%, N=1), Mental disorders 
(0.8%, N=1), and infectious and parasitic disease (0.8%, N=1).  Patients’ median time on 
Home-­‐based	  palliative	  care	  program	   	  10	  
service was 113 days (range 8 to 508 days).  For those patients who had been discharged 
during the 1 year window (N=92), the reasons for discharge included goals met (20.3%, 
N=25), hospice placement (19.5%, N= 24), death (14.6%, N=18), certification lapse due 
to hospitalization (13%, N=16), nursing home placement (3.3%, N=4), no longer met 
criteria (2.4%. N=3), switched services (0.8%, N=1) and moved out of area (0.8%, N=1). 
The remaining patients were active Care Choices patients as of March 7, 2015 (25.2%, 
N=31). A 52% response rate was found for both the Reid and Edmonton surveys. 
Patient satisfaction with Care Choices	  
 In order to assess patient satisfaction with Care Choices services, frequency 
analyses were performed on the responses to the RGT1 and RGT2. Analyses revealed 
that surveys were completed by patients 64.3% of the time and by the caregiver 35.7% of 
the time for RGT1, and by patients 59.3% of the time and caregivers 40.7% of the time at 
RGT2.  The average number of days between start of care and the first call was 68 (range 
11 to 177 days). The average number of days between RGT1 and RGT2 was 103 (range 
90 to 137). 
 Table 1 presents frequency data reflecting patients’ overall satisfaction with the 
program at both assessment periods. The frequency of patients rating their satisfaction as 
a four or five (very to extremely; usually to almost always) on a five-point scale was 
calculated.  Results revealed that at least 80% of respondents surveyed at RGT1 reported 
satisfaction on all questions except for the question “I have asked people in the program 
for information and have received it…” where 72.7% respondents reported satisfaction 
(Table 3). At RGT2, 95% or more of respondents reported satisfaction on all survey 
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questions except for the question “The information I have received in the program has 
been (helpful)” where 75% of respondents reported high satisfaction.  
 A paired samples T-test was conducted to compare changes in satisfaction from 
RGT1 to RGT2. Results revealed that there was a significant increase in satisfaction 
between RGT1 and RGT2 for all Reid-Gundlach survey questions except, “Overall I 
think the services provided by the Care Choices program are…” and “The information I 
have received in the program has generally been (easy to understand)…”(Table 2).   
 In	   order	   to	   test	   for	   a	   difference	   in	   responses	   provided	   by	   patients	   in	  comparison	   to	   caregivers,	   an	   independent	   groups	   t-­‐tests	   was	   conducted.	   For	   the	  question	   “The	   staff	   treats	   me	   like	   I	   am	   an	   individual	   with	   unique	   needs	   and	  concerns“	   at	   RGT1,	   caregivers	   had	   greater	   satisfaction	   (M=4.79,	   SD=0.41)	   than	  patients	  (M=4.50,	  SD=0.642);	  t(79)=-­‐2.22,	  p<0.05.	  Additionally	  for	  the	  question	  “The	  information	   I	   have	   received	   in	   the	   program	   has	   generally	   been	  (understandable)“means	   indicated	   that	   caregivers	   were	   more	   satisfied	   (M=1.29,	  SD=0.71)	   than	   patients	   (M=1.76,	   SD=0.96);	   t(76)=2.28,	   p<0.05.	   There	   were	   no	  significant	  differences	  found	  between	  patient	  and	  caregiver	  responses	  for	  RGT2. 
Quality of life 
 Frequency analyses revealed that the ESAST1 was completed by patients 65.2% 
of the time and by caregivers 34.8% of the time, and at ESAST2, 72.7 % of responses 
were from patients and 27.3% from caregivers.  Given the variability and time lag that 
occurred before patients or caregivers could be reached by phone, only patients 
responding within 16 days of enrollment were considered for baseline comparison. A	  paired	   samples	   t-­‐test	   was	   conducted	   to	   compare	   changes	   in	   quality	   of	   life	   from	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  ESAST1	  to	  ESAST2.	  Results	  revealed	  that	  there	  were	  no	  significant	  changes	  reported	  for	  any	  symptom	  (Table	  3).	  	   There	   was	   no	   significant	   difference	   found	   between	   patient	   and	   caregiver	  responses	   for	  ESAST1.	   In	  ESAST2,	   significantly	  higher	   scores	   for	  patient	   tiredness	  were	   reported	   by	   caregivers	   (M=6.87,	   SD=2.07)	   than	   for	   patients	   (M=4.32,	  SD=3.42);	   t(50)=-­‐2.68,	  p=0.01.	   Additionally,	   significantly	   higher	   scores	   for	   patient	  anxiety	  were	  reported	  by	  caregivers	  (M=3.71,	  SD=2.40)	  than	  for	  patients	  (M=1.97,	  SD=3.21);	  t(50)=-­‐2.06,	  p<0.05.	   Hospitalization	  records	  	   	  	  In	  order	   to	   test	   for	  changes	   in	  hospitalizations,	  paired	  samples	   t-­‐test	  were	  conducted	  comparing	  the	  average	  number	  of	  ER	  and	  in-­‐patient	  admissions	  pre-­‐	  and	  post-­‐	   enrollment	   to	   Care	   Choices.	   There	   was	   a	   significant	   decline	   in	   the	   average	  number	   of	   emergency	   room	   visits	   after	   enrollment	   in	   Care	   Choices	   (M=1.00,	  SD=1.08)	   compared	   to	   the	   average	   number	   of	   visits	   before	   enrollment	   (M=1.79,	  SD=1.46)	  t(81)=4.46,	  p<.0.001.	  	  The	  number	  of	  inpatient	  admissions	  to	  the	  hospital	  was	   also	   significantly	   lower	   after	   admission	   (M=	   0.38,	   SD=0.70)	   compared	   to	  hospitalizations	  occurring	  prior	   to	  enrollment	   in	   the	  program	  (M=	  1.21,	  SD=	  1.02)	  
t(81)=6.54,	  p<0.001	  (Table	  4).	  
Discussion 	  
These results suggest that the Care Choices program is achieving a number of 
desired outcomes.  For example, most patients reported that they were highly satisfied 
with the program and average satisfaction scores increased over time for those who 
continued in the program.  While the data indicates high levels of satisfaction with Care 
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Choices, slightly lower mean satisfaction scores were reported on indices related to 
information (i.e. whether it was received when requested, whether it was understandable, 
and whether it was easy to understand), a topic that can be addressed in staff training.   
Patient reports on quality of life did not change over time while on the program, 
indicating effective symptom management for the duration of the evaluation window.  
While reductions in symptoms reported did not decline over time, ratings for all 
symptoms tended to be below 4 and consistent with early reports on the program. This 
suggests that patients’ symptoms were being managed early on and were kept from 
escalating despite serious illness diagnoses usually characterized by trajectories of 
decline.  
Average scores for dyspnea, pain, nausea and anxiety were less than 5 at baseline 
and less than 4 at the follow up assessment, a sign that patients’ symptoms that often 
drive hospitalizations were being managed. New quality measure guidelines outlined 
from the American Academy of Hospice and Palliative Medicine and Hospice and 
Palliative Nurses Association suggest that pain treatment, dyspnea screening and 
management, and discussion of emotional or psychological needs are part of the top ten 
quality indicators.31 Therefore, Care Choices appears to be showing early signs of 
success in this regard.  
One of the most encouraging findings observed was a significant decline in both 
in-patient admissions and ER visits after enrollment in the Care Choices program.    
While hospitalization data was only available for patients admitted to the regional 
community hospital, the majority of patients in this study (88.6%) were from 
Schenectady County, the primary catchment area for this hospital.  These patients made 
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significantly fewer visits to the emergency room and were hospitalized significantly less 
often after enrollment in the program compared to the same time period prior to 
enrollment.  The results provide evidence that that the Care Choices program is achieving 
it’s goal of stabilizing patients, fulfilling their desire to remain at home, and preventing 
excess hospital resource use.  The significant decrease in emergency room visits and 
inpatient stays, while a quality of life and satisfaction issue for patients, is also a proxy 
for cost savings.  A comparison of cost per day indicates the cost savings.  For the first 
year of 2014, the Care Choices direct cost per day was $52.76 while the average inpatient 
stay for Ellis Hospital was $1,042.63 
Limitations 
There are a number of limitations that impact the conclusions that can be drawn in 
this report.   Our results are observational in nature. No attempt was made to randomize 
patients to one form of care compared to another.  Data collection was not blinded but no 
quality of life or experience of care questions were asked by those providing the 
care.  We did this intentionally to reduce observer bias.   
Although attempts were made to obtain data at pre-determined time points (i.e. 
baseline, 1-month post admission), patients were not always available or able to answer 
questions.  This led to variations in times considered “baseline” and “1-month follow 
up.”  In some cases baseline symptoms were not recorded until weeks on service after 
care visits had already occurred.  This may explain why declines in symptom reporting 
were not observed over time, as “baseline” was at a time during initial efforts to stabilize 
symptoms.  Furthermore, patients were not always willing or able to complete both 
satisfaction and symptom surveys, and only patients with both T1 and T2 data could be 
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included in analyses tracking change. Finally, during the yearlong tracking of patients, 
15% died and 20% were discharged to hospice.  Therefore, assessments on quality of life 
and satisfaction with the program could only be reported in a small group of enrollees.  
 Tracking the progress of patients in an in-home palliative care setting is 
challenging.  This is particularly true early in a pilot program when funding depends 
upon the outcomes under measurement.   Additional challenges exist when collecting 
longitudinal data on palliative care patients, as it may not be feasible or ethical to 
establish appropriate controls. Subjects are also seriously ill and frequently die or are too 
tired or ill to respond to survey questions. 32 While the overall response rate (52%) was in 
line with other studies33, we had to rely on assessments of caregivers about one-third of 
the time, as patients were not always able to respond to the telephone survey on their 
own.  Despite slight differences in satisfaction scores reported by caregivers and patients, 
scores on both indices averaged above 4 (usually or almost always) on a 5-point scale for 
both caregiver and patient populations, indicating high levels of satisfaction with the 
program for both. In RGT2 satisfaction scores there were no differences found, 
suggesting that as time progressed on the program, patients and caregivers were similarly 
satisfied. 
Studies comparing patient/caregiver dyads have shown that patients and 
caregivers share similar perceptions, that the magnitude of difference is small to 
moderate, and that differences are more marked for psychological than for physical 
symptoms.34-36 We were unable to examine whether there was concordance between 
patient and caregiver responses because caregivers answered questions only when the 
patient was unable to do so. In a recent report outlining the top 10 measures that matter 
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most in palliative care populations, it is recommended that input be obtained from both 
patients and caregivers when measuring quality in any care,12 an approach that we will 
consider in future assessments of our program.  
With the exception of tiredness and anxiety, analyses completed comparing 
patient responses against caregiver responses showed that in most cases there was not a 
significant difference. For tiredness and anxiety, caregivers rated symptoms higher than 
patients. This difference was also reported in a recent study finding that patients and 
caregivers differed in ratings of symptoms such as feeling drowsy, sad, worried and 
nervous36.  This difference has been attributed to potential difficulties in rating symptoms 
that tend to be more subjective, thereby making it harder for caregivers to gauge 
symptoms by using physical indicators.37 It has also been suggested that higher scores 
could be the result of caregivers who feel burdened, leading to a tendency to think that 
their loved one’s condition is worse then it really is.36 The	  results	  suggest	  that	  the	  Care 
Choices program is contributing to satisfaction among caregivers, something that could 
helping decrease caregiver depression and burden.35 Studies show there is an inverse 
association between caregiver depression and burden, and the caregiver’s sense of 
effective communication and care provided by health care professionals.35  
Although patients’ symptoms seemed to be managed well while on the Care 
Choices program, we were unable to determine whether it was this management of 
symptoms that led to fewer hospitalizations while enrolled in the Care Choices program. 
When hospitalization data was collected, the specific dates of hospitalization were not 
included. This limited our ability to determine whether more severe symptom reports 
could have lead to the hospitalizations that occurred during a patient’s time on the 
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program. In future studies, it would be interesting to see which symptoms, if any, may 
have prompted hospitalization.  
Conclusion	  This	  study	  offers	  some	  interesting	  results	  suggesting	  that	  Care	  Choices	  is	  meeting	  its	  projected	  goals.	  The	  results	  indicate	  that	  patients	  were	  satisfied	  with	  the	  care	  they	  were	  provided,	  their	  symptoms	  were	  stabilized,	  and	  they	  were	  less	  likely	  to	  be	  hospitalized.	  Care	  Choices	  represents	  a	  unique	  partnership	  between	  a	  community	  hospital	  and	  a	  visiting	  nurse	  service	  that	  serves	  a	  very	  diverse	  patient	  population	  from	  inner-­‐city,	  suburban,	  and	  rural	  regions	  of	  the	  Capital	  District	  of	  New	  York.	  	  The	  program	  is	  also	  unique	  in	  that	  it	  was	  designed	  to	  provide	  all-­‐inclusive	  services	  to	  patients	  who	  want	  to	  continue	  their	  regular	  care	  while	  on	  the	  program,	  thereby	  avoiding	  one	  of	  the	  main	  concerns	  reported	  by	  those	  considering	  programs	  such	  as	  the	  Program	  of	  All-­‐Inclusive	  Care	  for	  the	  Elderly	  (PACE).	  40	  	  	  As	  population	  health	  becomes	  the	  focus	  of	  healthcare	  organizations	  nationwide,	  grassroots	  palliative	  care	  initiatives	  are	  resulting	  in	  a	  myriad	  of	  models	  to	  meet	  the	  unique	  needs	  of	  the	  community	  at	  large.	  	  Recently,	  Gomes	  et	  al.,	  reviewed	  palliative	  care	  models	  coordinated	  through	  a	  wide	  variety	  of	  organizations	  including	  hospitals,	  hospices,	  managed	  care	  organizations,	  cancer	  centers,	  palliative	  medicine	  units,	  visiting	  nurse	  associations,	  veterans	  affairs,	  and	  outpatient	  clinics	  noting	  partnerships	  launching	  early	  phase	  trials,	  new	  interventions,	  pilot	  studies,	  as	  well	  as	  demonstration	  projects.	  	  Some	  palliative	  care	  programs	  have	  targeted	  specific	  patient	  populations	  (multiple	  sclerosis,	  cancer,	  AIDS,	  only	  non-­‐cancer	  diagnoses	  such	  as	  COPD)	  while	  others,	  like	  ours,	  have	  included	  mixed	  patient	  populations. 41	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  it	  is	  clear	  that	  a	  “one	  size	  fits	  all”	  model	  will	  not	  suffice	  and	  outcomes	  and	  indicators	  of	  success	  may	  vary	  across	  programs	  as	  care	  moves	  out	  of	  institutional	  settings	  and	  in	  to	  patients’	  homes	  both	  by	  need	  and	  by	  desire40.	  	  Reductions	  in	  hospitalizations	  have	  been	  reported	  in	  some	  “Hospital	  at	  Home”	  programs	  where	  acute	  level	  care	  was	  provided	  in	  patients’	  homes42	  but	  not	  all	  have	  resulted	  in	  reduced	  hospitalizations. 43	  While	  reduced	  hospitalizations	  should	  not	  be	  the	  driving	  force	  behind	  in-­‐home	  palliative	  care	  programs,	  it	  is	  an	  important	  outcome	  not	  only	  for	  cost-­‐savings	  but	  also	  for	  the	  prevention	  of	  hospital-­‐	  associated	  infections	  and	  avoidance	  of	  environments	  that	  can	  disrupt	  sleep,	  mobility,	  and	  daily	  routines	  associated	  with	  well-­‐being.	  	  Care	  Choices	  enrollees	  not	  only	  reported	  increased	  satisfaction	  and	  stable	  symptom	  management	  over	  time;	  they	  exhibited	  a	  significant	  reduction	  in	  both	  ER	  visits	  and	  in-­‐patient	  hospitalizations.	  	  	  Like	  Care	  Choices,	  programs	  that	  show	  the	  most	  success	  in	  keeping	  patients	  out	  of	  the	  hospital	  are	  those	  that	  have	  relied	  on	  a	  comprehensive	  team	  of	  providers	  offering	  a	  wide	  range	  of	  services	  including;	  support	  services	  for	  at	  home	  oxygen	  use,	  skilled	  therapies	  and	  pharmacy	  arrangements42.	  One	  in-­‐care	  home	  program	  replaced	  acute	  care	  hospital	  visits	  entirely.42	  In	  order	  to	  do	  so,	  patients	  were	  chosen	  based	  on	  diagnosis	  so	  that	  all	  treatments	  were	  guaranteed	  to	  be	  delivered	  in	  home.	  
Care	  Choices	  does	  not	  have	  these	  same	  restrictions	  leading	  some	  treatments	  to	  be	  administered	  outside	  the	  home,	  but	  this	  approach	  allows	  a	  broader	  population	  of	  patients	  to	  access	  the	  program.	  In	  studies	  that	  did	  not	  show	  a	  reduction	  of	  hospitalization,	  there	  was	  concern	  that	  patients	  were	  not	  enrolled	  early	  enough	  for	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  intervention	  in	  care	  management	  to	  occur.43	  Most	  patients	  in	  the	  study	  by	  Grande	  et	  al.	  did	  not	  make	  the	  transition	  into	  in-­‐home	  care	  until	  a	  few	  months	  to	  a	  few	  weeks	  before	  death.	  The	  Care	  Choices	  program’s	  success	  may	  have	  been	  due,	  in	  part,	  to	  its	  connection	  to	  CHAH	  and	  referral	  from	  the	  VNS	  so	  that	  palliative	  care	  treatment	  could	  begin	  early.	  	  
In the future it has been suggested that there is a need for studies to show 
medication reconciliation and management of pharmaceuticals for patients at home.38 In 
chronically ill populations with multiple physicians, medication errors like medication 
duplication between physicians and inconsistencies with patients using medications that 
physicians told them to omit are particularly common.38 Physicians have also been shown 
to prescribe a more expensive drug due to lack of knowledge of less expensive options.39 
These extra pharmaceutical costs can have a significant effect on the amount that a 
patient’s healthcare can cost. Management of these costs could help decrease expenses of 
in home care and help secure more health insurance coverage for patients.  Currently,	  this	  study	  provides	  evidence	  of	  a	  successful	  collaboration	  between	  a	  community	  hospital	  and	  visiting	  nurse	  service	  that	  was	  able	  to	  offer	  the	  full	  spectrum	  of	  palliative	  care	  services	  in	  patients’	  home	  thereby	  satisfying	  their	  desire	  to	  remain	  at	  home,	  manage	  their	  symptoms,	  remain	  with	  their	  regular	  outside	  care	  providers,	  and	  reduce	  unnecessary	  hospitalizations.	  	  In	  development	  are	  shared	  savings	  and	  bundled	  payment	  mechanisms	  for	  palliative	  home	  care	  as	  part	  of	  Accountable	  Care	  Organizations	  (ACO’s)	  and	  the	  New	  York	  State	  Delivery	  System	  Reform	  Incentive	  Payment	  (DSRIP)	  program	  being	  designed	  for	  Medicaid	  patients	  in	  New	  York	  State.	  	  Hopefully,	  the	  many	  Center	  for	  Medicare	  and	  Medicaid	  Services	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  (CMS)	  Innovation	  projects	  currently	  underway,	  as	  well	  as	  the	  Hospice	  concurrent	  care	  project,	  will	  result	  in	  Medicare	  establishing	  payment	  models	  for	  palliative	  home	  care	  within	  the	  standard	  Medicare	  program,	  similar	  to	  the	  Hospice	  Part	  A	  Medicare	  Benefit.	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       Table 1.  Satisfaction scores of 4 or 5 on the Reid-Gundlach Satisfaction Survey  
	  	  	  	  	  	  	  	  
Question Time 1 
Percent 
Satisfied 
% (N) 
Time 2 
Percent 
Satisfied  
% (N) 
 Usually or Almost Always 
1. The people that I have been involved with answer 
my questions  
90.1 (73) 96 (24) 
2. The people I have come in contact with have been 
very helpful in explaining the services I need  
90.3 (74)  100 (25) 
3. The staff treats me like I am an individual with 
unique needs and concerns 
97.5 (79) 100 (25) 
4. The staff is available to help me when I have 
questions  
88.5 (69) 100 (25) 
5. The staff understands the service needs of patients 
with serious illness 
88.5 (69) 100 (25) 
6. I have asked people in the program for information 
and have received it 
72.7 (56) 100(24) 
7. Would you tell your friends that they should use 
these services if they had needs like yours 
 91.3 (73) 100(26) 
 Very Good or Excellent 
8. Overall I think the services provided by the Care 
Choices program are 
85.4 (70) 96.3 (26) 
 Very Helpful or Extremely 
Helpful 
9. The information I have received as been 83.8 (67) 100 (25) 
 Somewhat Easy to Understand 
or Easy to Understand  
10. The information I have received in the program 
has generally been 
85.9 (67) 75.0(18) 
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Table 2. Average ratings of satisfaction from Reid-Gundlach Satisfaction Survey at time 
1 and time 2 (0=unsatisfied; 5=satisfied) 	   Question	  	   Time	  1	  	  M	  (SD)	   Time	  2	  M	  (SD)	   t	   df	   p	  
1. The people that I have 
been involved with 
answer my questions. 	   4.48(0.59)	   4.84(0.47)	   -­‐2.22	   24	   0.036*	  
2. The people I have come 
in contact with have been 
very helpful in explaining 
the services I need. 	  
4.17(0.92)	   4.96(0.20)	   -­‐4.39	   23	   0.000***	  
3. The staff treats me like 
I am an individual with 
unique needs and 
concerns.	  
4.52(0.59)	   4.87(0.34)	   -­‐2.34	   22	   0.029*	  
4. The staff is available to 
help me when I have 
questions. 	   4.54(0.66)	   4.96(0.20)	   -­‐2.85	   23	   0.009**	  
5. The staff understands 
the service needs of 
patients with serious 
illness.	  
4.54(0.66)	   4.96(0.20)	   -­‐2.85	   23	   0.009**	  
6. I have asked people in 
the program for 
information and have 
received it.	  
3.61(1.56)	   4.87(0.34)	   -­‐3.994	   22	   0.001**	  
7. Would you tell your 
friends that they should 
use these services if they 
had needs like yours?	  
4.54(0.58)	   4.92(0.27)	   -­‐3.43	   25	   0.002**	  
8. Overall I think the 
services provided by the 
Care Choices program 
are… 
4.33(0.78)	   4.63(0.57)	   -­‐1.55	   26	   0.133	  
9. The information I have 
received as been (helpful). 
4.00(0.91)	   4.48(0.51)	   -­‐2.21	   22	   0.038*	  
10. The information I 
have received in the 
program has generally 
been (easy to understand). 
(1=easy, 5= difficult) 
1.59(0.85)	   1.68(1.36)	   -­‐0.271	   21	   0.79	  
	  	  *     p<.05	  
**   p<.01	  
*** p<.001 
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Table 3. Average ratings of symptoms from Edmonton Symptom Assessment Survey at 
ESAST1 and ESAST2 (0=best; 10=worst) 
 
 
Symptom Baseline 
M (SD) 
Follow-up 
M (SD) 
t df p 
Pain 3.30(3.05) 2.30(3.11) 1.43 19 0.169 
Nausea 0.91(2.13) 0.70(1.64) 0.43 22 0.670 
Tiredness 4.52(2.46) 4.43(3.19) 0.18 20 0.860 
Depression 1.74(2.70) 1.39(1.99) 0.82 22 0.421 
Anxiety 2.55(2.72) 2.00(2.64) 1.015 21 0.322 
Drowsiness 3.24(2.57) 3.38(3.19) -0.22 20 0.825 
Appetite 4.35(2.81) 4.26(3.11) 0.10 22 0.926 
Wellbeing 4.04(2.65) 4.00(2.52) 0.08 22 0.940 
Shortness of 
Breath 
4.09(3.23) 3.26(3.45) 1.37 22 0.184 
	  
*     p<.05	  
**   p<.01	  
*** p<.001	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Table	  4. Average number and type of hospital admissions pre- and post-enrollment to 
Care Choices	  	  	  
Hospitalization	   Pre	  
M (SD)	   Post	  M (SD)	   t	   df	   p	  
Emergency Room	   1.79(1.46)	   1.00(1.08)	   4.46	   80	   0.000***	  
Inpatient	   1.21(1.02)	  	   0.38(0.70)	   6.54	   80	   0.000***	  
*    p<.05	  
**  p<.01	  
***p<.001	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